10/13/2026
At MSK, rhabdomyosarcoma is not rare to us. During our one-day symposium this Monday, October 19, Rhabdomyosarcoma 2026: Advancing Science, Improving Outcomes, experts will share insights into the critical balance between optimizing treatment outcomes and minimizing toxicities associated with chemotherapy and radiation therapy. Discussions will also highlight innovative surgical and radiation techniques aimed at mitigating long-term side effects and improving patient outcomes.
Join us in person or virtually to learn more about the latest advances and evolving approaches to rhabdomyosarcoma care. Learn more and register at http://bit.ly/MSKRhabdoCME